As per the research report, the size of the Asia Pacific Dermatology Diagnostic Devices market was valued at USD 4.9 billion in 2020. It is expected to grow at a CAGR of 7.8% to reach USD 7.14 billion by 2025 during the forecast period 2020-2025. It captures 20% of the global market.
Dermatology devices are expected to grow at a faster rate due to rising concern amongst people regarding aesthetics. This has led to rising awareness about various types of aesthetic procedures used for treating hair- and skin-related disorders. Primarily, women suffer from these disorders. Therefore, they are the highest revenue makers in the market.
Increasing the incidence of skin disorders, growing awareness regarding aesthetic procedures, technological advancements, and rising healthcare expenditure are the primary drivers of the market.
This research report segmented and sub-segmented into the following categories:
The imaging devices category is anticipated to command the largest share of the market during the aforementioned forecast period. It is due to the technological advancements and rising awareness regarding aesthetic procedures. The skin cancer diagnosis segment is expected to account for the largest share of the market during the forecast period.
It is the third-largest market. Asia is anticipated to experience the highest CAGR during the aforementioned forecast period, with the development in this market centered on Japan, China, and India. Increasing the incidence of skin diseases, rising healthcare expenditure, and growing awareness regarding aesthetic procedures are the reasons attributable to the observable trend mentioned above.
The Top companies leading in the APAC Dermatology Diagnostic Devices Market profiled in the report are 3Gen Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss (Germany), Genesis Biosystems, Inc. (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), Lumenis Ltd. (Israel), Valeant Pharmaceuticals (Canada), HEINE Optotechnik GmbH & Co. KG (Germany), Michelson Diagnostics (U.K.), and PhotoMedex, Inc. (U.S.).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Skin Cancer Diagnosis
5.1.3 Other Diagnostic Applications
5.1.4 Y-o-Y Growth Analysis, By Application
5.1.5 Market Attractiveness Analysis, By Application
5.1.6 Market Share Analysis, By Application
5.2.2 Imaging Devices
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3.1 Contact Oil Immersion Dermatoscopes
5.3.2 Cross-Polarized Dermatoscopes
5.3.3 Hybrid Dermatoscopes
5.3.4 Y-o-Y Growth Analysis, By Dermatoscopes
5.3.5 Market Attractiveness Analysis, By Dermatoscopes
5.3.6 Market Share Analysis, By Dermatoscopes
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Application
220.127.116.11 By Type
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Application
126.96.36.199 By Type
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Application
220.127.116.11 By Type
6.6 South Korea
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Alma Lasers, Ltd.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cutera, Inc.
8.3 Cynosure, Inc.
8.4 Lumenis, Ltd.
8.5 Valeant Pharmaceuticals International, Inc.
8.6 3Gen, Inc.
8.7 Bruker Corporation
8.8 Carl Zeiss
8.9 Genesis Biosystems, Inc.
8.10 Heine Optotechnik GmbH & Co. Kg
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures